rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-24
|
pubmed:abstractText |
In pediatric meningococcal sepsis, an imbalance between coagulation and fibrinolysis and proinflammatory action play major roles. We hypothesized that thrombin activatable fibrinolysis inhibitor (TAFI) and/or TAFI activation markers are involved in the pathogenesis of meningococcal sepsis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1538-7836
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
268-76
|
pubmed:meshHeading |
pubmed-meshheading:18021301-Adolescent,
pubmed-meshheading:18021301-Carboxypeptidase U,
pubmed-meshheading:18021301-Child,
pubmed-meshheading:18021301-Child, Preschool,
pubmed-meshheading:18021301-Disseminated Intravascular Coagulation,
pubmed-meshheading:18021301-Enzyme Activation,
pubmed-meshheading:18021301-Female,
pubmed-meshheading:18021301-Genetic Predisposition to Disease,
pubmed-meshheading:18021301-Genotype,
pubmed-meshheading:18021301-Humans,
pubmed-meshheading:18021301-Infant,
pubmed-meshheading:18021301-Male,
pubmed-meshheading:18021301-Meningococcal Infections,
pubmed-meshheading:18021301-Mutation, Missense,
pubmed-meshheading:18021301-Neisseria meningitidis,
pubmed-meshheading:18021301-Point Mutation,
pubmed-meshheading:18021301-Serotyping,
pubmed-meshheading:18021301-Severity of Illness Index,
pubmed-meshheading:18021301-Shock, Septic,
pubmed-meshheading:18021301-Survival Analysis,
pubmed-meshheading:18021301-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children.
|
pubmed:affiliation |
Department of Pediatrics, Erasmus MC-Sophia, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|